Around a quarter of a million people living with obesity will be offered the weight loss drug tirzepatide over the next three years, final draft guidance from NICE has outlined. The medicine is recomm...
Researchers at Leicester Diabetes Centre (LDC) have successfully started using the glucose clamp technique as part of a new diabetes research trial. The gold-standard technique measures how sensitive ...
A Phase 3 study in The New England Journal of Medicine found that tirzepatide was associated with lower risk of progression to type 2 diabetes among adults with prediabetes and obesity or overweight. ...
Healthcare professionals are invited to take part in two nationwide audits collecting data about the use of continuous glucose monitoring (CGM) in people living with type 2 diabetes. The Association o...
A trial evaluating the efficacy of a unique keratin matrix graft to treat chronic diabetic foot ulcers found a “high rate of complete healing”. The multicentre trial examined the outcomes of two appli...
The share of people with type 1 diabetes who are prescribed a GLP-1 receptor agonist or SGLT2 inhibitor rose from 0.7 per cent to 8.3 per cent between 2010 and 2023, evidence has shown. According to a...
A diabetes specialist nurse from the University Hospitals Leicester NHS Trust is celebrating after picking up two renowned health accolades for his “dedication to education and support”. James Ridgewa...
A new eLearning course to improve the treatment and management of early onset type 2 diabetes has been launched by Effective Diabetes Education Now (EDEN). Entitled ‘Early Onset T2 Day Education Prog...
A set of new practical recourses to help address some common gaps in diabetes care have been released. Insights for Diabetes Excellence, Access and Learning (iDEAL) Diabetes has developed the resource...